B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SLC34A2

MOLECULAR TARGET

solute carrier family 34 member 2

UniProt: O95436NCBI Gene: 105681 compounds

SLC34A2 (solute carrier family 34 member 2) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SLC34A2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Crizotinib0.691

About SLC34A2 as a Drug Target

SLC34A2 (solute carrier family 34 member 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented SLC34A2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SLC34A2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.